Intellectual Property India Publishes Patent Application for 'Solid Forms Of A Triazine Derivative As CBL-B Modulator' Filed by Hotspot Therapeutics, Inc.

MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202517011438 A) filed by Hotspot Therapeutics, Inc., Boston, on Feb. 11, for 'solid forms of a triazine derivative as cbl-b modulator.'

Inventor(s) include Lawson, Jon P.; Carson, Ken; and Bi, Yingzhi.

The application for the patent was published on May 9, under issue no. 19/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure provides, in part, provides crystalline forms of the compound of formula (I). Also provided are pharmaceutical compositions including a crystalline form of the compound of formula (I), as well as the crystalline forms of the compound for use in methods of treating various condition...